The human fetal adrenal gland, corticotropin-releasing hormone, and parturition

Seminars in Reproductive Medicine

Volumn 25, Issue 1, 2007, Pages 14-20

  Beshay, Victor E ^b   Carr, Bruce R ^a   Rainey, William E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adrenal; Corticotropin releasing hormone (CRH); Labor initiation; Parturition

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ADRENAL GLAND; BIRTH; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LABOR; MEDICAL RESEARCH; PREDICTION; PREMATURE LABOR; REVIEW; SIGNAL TRANSDUCTION;

ADRENAL GLANDS; CORTICOTROPIN-RELEASING HORMONE; DEHYDROEPIANDROSTERONE SULFATE; ESTRIOL; FEMALE; HUMANS; HYDROCORTISONE; OBSTETRIC LABOR, PREMATURE; PARTURITION; PREGNANCY;

EID: 33846432004     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-956772     Document Type: Review

References (68)

1. Liggins GC, Fairclough RJ, Grieves SA, et al. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973;29:111-159
2. Liggins GC, Kennedy PC, Holm LW. Failure of initiation of parturition after electrocoagulation of the pituitary of the fetal lamb. Am J Obstet Gynecol 1967;98(8):1080-1086
3. Challis JR, Sloboda D, Matthews SG, et al. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol 2001;185(1-2):135-144
4. Challis JRG, Matthews SG, Gibb W, et al. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21(5):514-550
5. Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966;26(7):751-761
6. Simmer HH, Easterling J, Pion RJ, et al. Neutral C19-steroids and steroid sulfates in human pregnancy. I. Identification of dehydroepiandrosterone sulfate in fetal blood and quantification of this hormone in cord arterial, cord venous and maternal peripheral blood in normal pregnancies at term. Steroids 1964;4(1):125-135
7. Lac G, Marquet P, Chassain AP, et al. Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones. J Appl Physiol 1999;87(1):183-188
8. Spencer SJ, Mesiano S, Lee JY, et al. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab 1999;84(3):1110-1115
9. Rainey WE, Carr BR, Wang ZN, et al. Gene profiling of human fetal and adult adrenals. J Endocrinol 2001;171(2):209-215
10. Bassett MH, Suzuki T, Sasano H, et al. The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase: implications for the control of adrenal functional zonation. J Biol Chem 2004;279(36):37622-37630
11. Bassett MH, White PC, Rainey WE. A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res 2004;30(4):567-574
12. Coulter CL, Goldsmith PC, Mesiano S, et al. Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology 1996;137(10):4487-4498
13. Suzuki T, Sasano H, Takeyama J, et al. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000;53(6):739-747
14. Mesiano S, Coulter CL, Jaffe RB. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17, 20-lyase, and 3 beta-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab 1993;77(5):1184-1189
15. Shifren JL, Mesiano S, Taylor RN, et al. Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998;83(4):1342-1347
16. Mesiano S, Jaffe RB. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 1997;62(1):62-72
17. Parker CR Jr, Stankovic AM, Goland RS. Corticotropin-releasing hormone stimulates steroidogenesis in cultured human adrenal cells. Mol Cell Endocrinol 1999;155(1-2):19-25
18. Smith R, Mesiano S, Chan EC, et al. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998;83(8):2916-2920
19. Sirianni R, Rehman KS, Carr BR, et al. Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metab 2005;90(1):279-285
20. Sirianni R, Mayhew BA, Carr BR, et al. Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J Clin Endocrinol Metab 2005;90(9):5393-5400
21. Jingami H, Matsukura S, Numa S, et al. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 1985;117(4):1314-1320
22. Goland RS, Wardlaw SL, Stark RI, et al. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986;63(5):1199-1203
23. Lockwood CJ, Radunovic N, Nastic D, et al. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 1996;24(3):243-251
24. Stalla GK, Bost H, Stalla J, et al. Human corticotropin-releasing hormone during pregnancy. Gynecol Endocrinol 1989;3(1):1-10
25. Robinson BG, Emanuel RL, Frim DM, et al. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988;85(14):5244-5248
26. Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin- releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989;68(4):825-830
27. Karalis K, Majzoub JA. Regulation of placental corticotropin-releasing hormone by steroids. Possible implications in labor initiation. Ann NY Acad Sci 1995;771:551-555
28. Marinoni E, Korebrits C, Di Iorio R, et al. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998;178(4):770-778
29. Carr BR, Parker CR Jr, Madden JD, et al. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981;139(4):416-422
30. Casey ML, MacDonald PC, Mitchell MD. Despite a massive increase in cortisol secretion in women during parturition, there is an equally massive increase in prostaglandin synthesis. A paradox? J Clin Invest 1985;75(6):1852-1857
31. Dorr HG, Heller A, Versmold HT, et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989;68(5):863-868
32. Vale W, Spiess J, Rivier C, et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213(4514):1394-1397
33. Riley SC, Walton JC, Herlick JM, et al. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991;72(5):1001-1007
34. Scatena CD, Adler S. Characterization of a human-specific regulator of placental corticotropin-releasing hormone. Mol Endocrinol 1998;12(8):1228-1240
35. Sorem KA, Smikle CB, Spencer DK, et al. Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies. Am J Obstet Gynecol 1996;175(4 pt 1):912-916
36. Frim DM, Emanuel RL, Robinson BG, et al. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988;82(1):287-292
37. Inder WJ, Prickett TC, Ellis MJ, et al. The utility of plasma CRH as a predictor of preterm delivery. J Clin Endocrinol Metab 2001;86(12):5706-5710
38. Hobel CJ, Arora CP, Korst LM. Corticotrophin-releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension. Ann NY Acad Sci 1999;897:54-65
39. Korebrits C, Ramirez MM, Watson L, et al. Maternal corticotropin- releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998;83(5):1585-1591
40. Chan EC, Falconer J, Madsen G, et al. A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep. Endocrinology 1998;139(7):3357-3360
41. Linton EA, Wolfe CD, Behan DP, et al. A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin Endocrinol (Oxf) 1988;28(3):315-324
42. Orth DN, Mount CD. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun 1987;143(2):411-417
43. Florio P, Woods RJ, Genazzani AR, et al. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. J Clin Endocrinol Metab 1997;82(3):835-838
44. Petraglia F, Florio P, Simoncini T, et al. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Placenta 1997;18(2-3):115-119
45. Perkins AV, Wolfe CD, Eben F, et al. Corticotrophin-releasing hormone-binding protein in human fetal plasma. J Endocrinol 1995;146(3):395-401
46. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002;23(2):71-77
47. Grammatopoulos D, Dai Y, Chen J, et al. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 1998;83(7):2539-2544
48. Karteris E, Randeva HS, Grammatopoulos DK, et al. Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J Clin Endocrinol Metab 2001;86(9):4512-4519
49. Winters AJ, Oliver C, Colston C, et al. Plasma ACTH levels in the human fetus and neonate as related to age and parturition. J Clin Endocrinol Metab 1974;39(2):269-273
50. Klimaviciute A, Calciolari J, Bertucci E, et al. Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state. Reprod Biol Endocrinol 2006;4(1):29
51. Hillhouse EW, Grammatopoulos DK. Role of stress peptides during human pregnancy and labour. Reproduction 2002;124(3):323-329
52. McGrath S, Smith R. Corticotrophin-releasing hormone and parturition. Clin Endocrinol (Oxf) 2001;55(5):593-595
53. Petraglia F, Florio P, Benedetto C, et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 1999;84(4):1420-1423
54. Benedetto C, Petraglia F, Marozio L, et al. Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. Am J Obstet Gynecol 1994;171(1):126-131
55. Florio P, Lombardo M, Gallo R, et al. Activin A corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta 1996;17(5-6):307-311
56. Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J Clin Endocrinol Metab 2005;90(12):6569-6574
57. Challis JR. CRH, a placental clock and preterm labour. Nat Med 1995;1(5):416
58. McLean M, Bisits A, Davies J, et al. A placental clock controlling the length of human pregnancy. Nat Med 1995;1(5):460-463
59. McLean M, Bisits A, Davies J, et al. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations. Am J Obstet Gynecol 1999;181(1):207-215
60. Coleman MA, France JT, Schellenberg JC, et al. Corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor. Am J Obstet Gynecol 2000;183(3):643-648
61. Campbell MK, Challis JR, DaSilva O, et al. A cohort study found that white blood cell count and endocrine markers predicted preterm birth in symptomatic women. J Clin Epidemiol 2005;58(3):304-310
62. Sibai B, Meis PJ, Klebanoff M, et al. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. Am J Obstet Gynecol 2005;193(3 Pt 2):1181-1186
63. Vogel I, Thorsen P, Curry A, et al. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 2005;84(6):516-525
64. McGregor JA, Jackson GM, Lachelin GC, et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995;173(4):1337-1342
65. Ellis MJ, Livesey JH, Inder WJ, et al. Plasma corticotropin-releasing hormone and unconjugated estriol in human pregnancy: gestational patterns and ability to predict preterm delivery. Am J Obstet Gynecol 2002;186(1):94-99
66. Shams M, Kilby MD, Somerset DA, et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998;13(4):799-804
67. Murphy VE, Clifton VL. Alterations in human placental 11beta-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 2003;24(7):739-744
68. Alfaidy N, Li W, Macintosh T, et al. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 2003;88(10):5033-5038